
KBV boss Gassen criticizes austerity measures and the obligation to report appointments, while substitute health insurance companies reject the allegations.
AI-generated summary
The federal government is planning cost-cutting measures in statutory health insurance that will burden the outpatient sector with around 2.7 billion euros.
Statutory health insurance doctors in Germany expect that from next year people with statutory health insurance will have to wait significantly longer for a doctor's appointment than before. The chairman of the National Association of Statutory Health Insurance Physicians (KBV), Andreas Gassen, referred to the reduction in funding for outpatient care in Bild. As a result, “more than 50 million appointments” were canceled. The shortage of appointments will therefore continue to worsen, said Gassen.
The federal government's savings program for statutory health insurance (GKV) provides for extensive cost-cutting measures. According to the KBV, the outpatient sector is particularly badly affected. The planned cuts in this area amount to around 2.7 billion euros for the coming year alone. A large part of the savings should be achieved by capping expenses.
The KBV had already criticized this extended “appointment reporting requirement” as part of the recently decided reform of emergency care. Previously, contracted doctors were obliged to report available appointments to the appointment service center. You could therefore determine the scope yourself. In the future there will be fixed quotas for appointments that you have to report.
This will not mean that patients can get appointments more quickly, said Gassen. “On the contrary: if a fixed contingent of appointments to be reported is set and these are blocked in the practices, they will no longer be available to the patients in these practices,” said the head of the statutory health insurance physicians. The KBV has repeatedly pointed this out, emphasized Gassen. More money is needed for outpatient care - this is the only way more appointments can be created.
The Association of Substitute Insurance Funds (vdek) criticized that with his statements the KBV boss was "deliberately stirring up fears among millions of legally insured people". The KBV is “painting a specter of service cuts and endless queues on the wall” and is “carrying out a political discussion on the backs of the patients,” explained vdek chairwoman Ulrike Elsner.
The claim that millions of appointments will be canceled in the future is particularly absurd. The fact that in the future practices will also have to report available appointments to the appointment service points (116117) “does not take any capacity out of the system, but rather ensures reliable placement based on medical urgency,” said Elsner.

A dispute breaks out between the National Association of Statutory Health Insurance Physicians (KBV) and the National Association of Statutory Health Insurance Funds over the effects of the Statutory Health Insurance Contribution Rate Stabilization Act on the availability of outpatient doctor's appointments for those with statutory health insurance.
According to a Forsa survey for DAK-Gesundheit, resistance to the time change in Germany has fallen to 71 percent. There has been a decline in rejection, particularly among young adults.

The chairman of the National Association of Statutory Health Insurance Physicians, Andreas Gassen, warns that those with statutory health insurance will have even longer waiting times for doctor's appointments in the future due to the federal reform of outpatient care. He criticizes the cuts in funding and the introduction of fixed appointment registration quotas, which, according to him, reduce the availability of appointments and exacerbate the two-tier system in the healthcare system.

The head of the Charité, Heyo Kroemer, criticizes the austerity package in the healthcare system decided by the federal government. He accuses the government of alleging that it is intended to relieve the burden on health insurance companies, but instead increases administrative costs in hospitals and could lead to a loss of revenue of 80 million euros. Kroemer warns of possible contract expirations for temporary doctors and emphasizes that the package is not a structural consideration, but rather a general savings.
A research team at the University of Exeter has discovered that the hospital fungus Candidozyma auris develops resistance to drugs through genome copies and the “Crazy-one” gene. The pathogen poses a global threat to intensive care units.

The pharmaceutical company Sanofi has started building a new insulin factory worth around two billion euros in Frankfurt am Main. The plant is expected to be operational by 2032, making the European insulin supply crisis-proof and securing thousands of jobs.